I agree. But even in the stagnant market it has value. No way it's worth less than $200 million worldwide. That's larger than the current market cap before Stendra. I really don't think there is much question about that. So any downside from here is just retail short games and won't last.
No that does not help. In fact it makes you sound like terrified short from a buck.
What are the worldwide rights to the two drugs worth? And in addition throw in a public company and sales team in place. If you are a privately held bio you could diversify whatever you have thru leverage and become public thru a buyout of VVUS. In that scenario I could see $5 or $6 but my basic question you dodged remains. What's the value of the company and approved drugs?
I see the math here as pretty straight forward. Cash balances out debt.
Qysimia and Stedra value = buyout... Sales of each have been a challenge, but they both have value. The question is what? Divide it by 104 million shares.
I see $2.37 as the next level once we finish this rest. The sooner the retailers locking in their quick 20 cent profit get out of the way the sooner we get going.
Feels like the retailers gave away some today... Short breather then a rip upward. Remember the sideline get's you nothing but a view of someone else making your gain.
Sideline is no place for gains.
He's real... And he's an avid investor... He even wrote a SA article about VVUS and APRI being a golden marriage about a year ago, for which I told him over and over again he was nuts... He's a VVUS fan, and in general a nice guy. That's the last I'm saying on it. You can look up his article if you so desire.
Carlos, I know you love VVUS... You should have jumped in around the $1.20s when I did VS. waiting for $1.50s... Regardless, yes you are Long VVUS stock as stated.
For those beating up on Carlos, it's worth knowing English is not his first language and he's a standup contributor to any stock he believes in and he has been an advocate for VVUS for sometime over on the APRI board.
I think everyone agrees LTBR is not in the nuclear business but more the fantasy business. They currently have ZERO partners as defined by another entity that shares the cost of business development in exchange for future revenue. They have ZERO products. They have ZERO customers.
All LTBR has is some drawings of fuel rods that have never been built or tested.
This entire thing is a scam that is marching toward delisting.
APRI is the far better choice... But stay here and wait, I'm sure DJW know what he's talking about. Look how great his $50 to $80 PPS by end of 2015 worked out.
Will they need imaginary fuel? Because if the plants in Vietnam need drawings of nuclear fuel rods that have never been built or tested then LTBR is in tremendous shape.
In the agreement to agree that later we will agree to try to agree to work together, isn't that the central question any real partner would need to #$%$.
What does LTBR actually contribute? What do they have hat is materially marketable?
The answer is drawing of fuel rods that have never been built or tested and a patent on those drawings. The reality is Seth has shopped this pretend fuel at any conference that would have him and to ny player in the space that would listen, and nobody wants it. Ask yourself why if the greatest minds in the Nuclear power business thought there was anything to LTBR's claims how the market cap would only be $10 million? For World wide nuclear players that's a rounding error.
LTBR is a fraud... Plain and simple.